| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $32.05B | $26.11B | $32.64B |
| YoY Revenue Growth % | +22.7% | -20.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.01B | $5.29B | $5.90B |
| Operating Margin % | 12.5% | 20.2% | 18.1% |
| Net Income (GAAP) | $3.40B | $4.48B | $5.00B |
| EBITDA (Normalized) | $5.16B | $6.23B | $7.08B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.25B | $3.25B | $6.32B |
| Capital Expenditures (CapEx) | $1.44B | $1.18B | $1.47B |
| Free Cash Flow (FCF) | $5.80B | $2.08B | $4.85B |
| FCF Margin % | 18.1% | 8.0% | 14.9% |
| Return on Invested Capital (ROIC %) | 2.0% | 3.2% | 19.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $188.30B | $156.11B | $9.17B |
| Total Stockholders' Equity | $23.34B | $17.25B | $18.80B |